Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 522

1.

Student perspectives on asthma management in schools: a mixed-methods study examining experiences, facilitators, and barriers to care.

Naman J, Press VG, Vaughn D, Hull A, Erwin K, Volerman A.

J Asthma. 2018 Oct 30:1-12. doi: 10.1080/02770903.2018.1534968. [Epub ahead of print]

PMID:
30376385
2.

Do Complexity Measures of Frontal EEG Distinguish Loss of Consciousness in Geriatric Patients Under Anesthesia?

Eagleman SL, Vaughn DA, Drover DR, Drover CM, Cohen MS, Ouellette NT, MacIver MB.

Front Neurosci. 2018 Sep 20;12:645. doi: 10.3389/fnins.2018.00645. eCollection 2018.

3.

Empathic Neural Responses Predict Group Allegiance.

Vaughn DA, Savjani RR, Cohen MS, Eagleman DM.

Front Hum Neurosci. 2018 Jul 31;12:302. doi: 10.3389/fnhum.2018.00302. eCollection 2018.

4.

Endothelial Regeneration of Large Vessels Is a Biphasic Process Driven by Local Cells with Distinct Proliferative Capacities.

McDonald AI, Shirali AS, Aragón R, Ma F, Hernandez G, Vaughn DA, Mack JJ, Lim TY, Sunshine H, Zhao P, Kalinichenko V, Hai T, Pelegrini M, Ardehali R, Iruela-Arispe ML.

Cell Stem Cell. 2018 Aug 2;23(2):210-225.e6. doi: 10.1016/j.stem.2018.07.011.

PMID:
30075129
5.

The "Jay-Dar" Phenomenon: Individuals Discriminate Cannabis Users from Nonusers Based Upon a Photograph.

Hirst RB, Conaboy C, Vaughn D, H Enriquez R, Wickham R.

Subst Use Misuse. 2018 Dec 6;53(14):2359-2367. doi: 10.1080/10826084.2018.1474228. Epub 2018 Jun 29.

PMID:
29958041
6.

Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations.

Pal SK, Rosenberg JE, Hoffman-Censits JH, Berger R, Quinn DI, Galsky MD, Wolf J, Dittrich C, Keam B, Delord JP, Schellens JHM, Gravis G, Medioni J, Maroto P, Sriuranpong V, Charoentum C, Burris HA, Grünwald V, Petrylak D, Vaishampayan U, Gez E, De Giorgi U, Lee JL, Voortman J, Gupta S, Sharma S, Mortazavi A, Vaughn DJ, Isaacs R, Parker K, Chen X, Yu K, Porter D, Graus Porta D, Bajorin DF.

Cancer Discov. 2018 Jul;8(7):812-821. doi: 10.1158/2159-8290.CD-18-0229. Epub 2018 May 30.

PMID:
29848605
7.

Using insurance claims to predict and improve hospitalizations and biologics use in members with inflammatory bowel diseases.

Vaughn DA, van Deen WK, Kerr WT, Meyer TR, Bertozzi AL, Hommes DW, Cohen MS.

J Biomed Inform. 2018 May;81:93-101. doi: 10.1016/j.jbi.2018.03.015. Epub 2018 Apr 3.

PMID:
29625187
8.

Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.

Kerns SL, Fung C, Monahan PO, Ardeshir-Rouhani-Fard S, Abu Zaid MI, Williams AM, Stump TE, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger C, Sahasrabudhe DM, Cook R, Fossa SD, Einhorn LH, Travis LB; Platinum Study Group.

J Clin Oncol. 2018 May 20;36(15):1505-1512. doi: 10.1200/JCO.2017.77.0735. Epub 2018 Apr 4.

PMID:
29617189
9.

Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer.

Vaughn DJ, Bellmunt J, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn DI, Culine S, Sternberg CN, Mai Y, Li H, Perini RF, Bajorin DF, de Wit R.

J Clin Oncol. 2018 Jun 1;36(16):1579-1587. doi: 10.1200/JCO.2017.76.9562. Epub 2018 Mar 28.

PMID:
29590008
10.

Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score.

Feldman DR, Ardeshir-Rouhani-Fard S, Monahan P, Sesso HD, Fung C, Williams AM, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Zaid MA, Lipshultz SE, Einhorn LH, Oeffinger KC, Travis LB, Fossa SD; Platinum Study Group.

Clin Genitourin Cancer. 2018 Aug;16(4):e761-e769. doi: 10.1016/j.clgc.2018.01.011. Epub 2018 Feb 5.

PMID:
29534941
11.

Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors.

Zaid MA, Gathirua-Mwangi WG, Fung C, Monahan PO, El-Charif O, Williams AM, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Althouse SK, Ardeshir-Rouhani-Fard S, Dinh PC Jr, Sesso HD, Einhorn LH, Fossa SD, Travis LB; Platinum Study Group.

J Natl Compr Canc Netw. 2018 Mar;16(3):257-265. doi: 10.6004/jnccn.2017.7046.

PMID:
29523664
12.

Cream of the Crop: Clinical Representativeness of Eligible and Ineligible Cannabis Users in Research.

Rosen AS, Sodos LM, Hirst RB, Vaughn D, Lorkiewicz SA.

Subst Use Misuse. 2018 Oct 15;53(12):1937-1950. doi: 10.1080/10826084.2018.1441312. Epub 2018 Mar 6.

PMID:
29509060
13.

Don't Judge a Book by its Cover: Examiner Expectancy Effects Predict Neuropsychological Performance for Individuals Judged as Chronic Cannabis Users.

Sodos LM, Hirst RB, Watson J, Vaughn D.

Arch Clin Neuropsychol. 2018 Nov 1;33(7):821-831. doi: 10.1093/arclin/acx114.

PMID:
29342226
14.

Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial.

Wong YN, Manola J, Hudes GR, Roth BJ, Moul JW, Barsevick AM, Scher RM, Volk MJ, Vaughn DJ, Williams SD, Fisch MJ, Cella D, Carducci MA, Wilding G.

Clin Genitourin Cancer. 2018 Apr;16(2):e315-e322. doi: 10.1016/j.clgc.2017.10.001. Epub 2017 Oct 16.

PMID:
29173976
15.

Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206.

Adra N, Einhorn LH, Althouse SK, Ammakkanavar NR, Musapatika D, Albany C, Vaughn D, Hanna NH.

Ann Oncol. 2018 Jan 1;29(1):209-214. doi: 10.1093/annonc/mdx680.

PMID:
29045540
16.

Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial.

Madan A, Collins H, Sheldon E, Frenette L, Chu L, Friel D, Drame M, Vaughn DW, Innis BL, Schuind A.

Vaccine. 2017 Aug 16;35(35 Pt B):4621-4628. doi: 10.1016/j.vaccine.2017.07.013. Epub 2017 Jul 15.

17.

Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.

Dolan ME, El Charif O, Wheeler HE, Gamazon ER, Ardeshir-Rouhani-Fard S, Monahan P, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Kim J, Fossa SD, Hertz DL, Mushiroda T, Kubo M, Einhorn LH, Cox NJ, Travis LB; Platinum Study Group.

Clin Cancer Res. 2017 Oct 1;23(19):5757-5768. doi: 10.1158/1078-0432.CCR-16-3224. Epub 2017 Jun 13.

18.

The Trauma Time-Out: Evaluating the Effectiveness of Protocol-Based Information Dissemination in the Traumatically Injured Patient.

Nolan HR, Fitzgerald M, Howard B, Jarrard J, Vaughn D.

J Trauma Nurs. 2017 May/Jun;24(3):170-173. doi: 10.1097/JTN.0000000000000286.

PMID:
28486323
19.

Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials.

van der Most RG, Clément F, Willekens J, Dewé W, Walravens K, Vaughn DW, Leroux-Roels G.

Clin Vaccine Immunol. 2017 Jun 5;24(6). pii: e00553-16. doi: 10.1128/CVI.00553-16. Print 2017 Jun.

20.

Evaluation of a web-based weight loss intervention in overweight cancer survivors aged 50 years and younger.

Lynch SM, Stricker CT, Brown JC, Berardi JM, Vaughn D, Domchek S, Filseth S, Branas A, Weiss-Trainor E, Schmitz KH, Sarwer DB.

Obes Sci Pract. 2017 Mar;3(1):83-94. doi: 10.1002/osp4.98. Epub 2017 Feb 24.

21.

Bilateral Lung Transplantation for Bleomycin-Associated Lung Injury.

Narayan V, Deshpande C, Bermudez CA, Golato JM, Lee JC, Diamond J, Vaughn DJ.

Oncologist. 2017 May;22(5):620-622. doi: 10.1634/theoncologist.2016-0437. Epub 2017 Mar 30.

22.

Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.

Fung C, Sesso HD, Williams AM, Kerns SL, Monahan P, Abu Zaid M, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Kollmannsberger CK, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Lipshultz SE, Einhorn LH, Fossa SD, Travis LB; Platinum Study Group.

J Clin Oncol. 2017 Apr 10;35(11):1211-1222. doi: 10.1200/JCO.2016.70.3108. Epub 2017 Feb 27.

23.

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.

Bellmunt J, de Wit R, Vaughn DJ, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn DI, Culine S, Sternberg CN, Mai Y, Poehlein CH, Perini RF, Bajorin DF; KEYNOTE-045 Investigators.

N Engl J Med. 2017 Mar 16;376(11):1015-1026. doi: 10.1056/NEJMoa1613683. Epub 2017 Feb 17.

24.

Spatial and Temporal Distribution of Polycyclic Aromatic Hydrocarbons and Elemental Carbon in Bakersfield, California.

Noth EM, Lurmann F, Northcross A, Perrino C, Vaughn D, Hammond SK.

Air Qual Atmos Health. 2016 Dec;9(8):899-908. doi: 10.1007/s11869-016-0399-y. Epub 2016 Apr 9.

25.

Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.

Wheeler HE, Gamazon ER, Frisina RD, Perez-Cervantes C, El Charif O, Mapes B, Fossa SD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Kollmannsberger C, Kim J, Mushiroda T, Kubo M, Ardeshir-Rouhani-Fard S, Einhorn LH, Cox NJ, Dolan ME, Travis LB.

Clin Cancer Res. 2017 Jul 1;23(13):3325-3333. doi: 10.1158/1078-0432.CCR-16-2809. Epub 2016 Dec 30.

26.

Particle count and black carbon measurements at schools in Las Vegas, NV and in the greater Salt Lake City, UT area.

Brown SG, Vaughn DL, Roberts PT.

J Air Waste Manag Assoc. 2017 Nov;67(11):1192-1204. doi: 10.1080/10962247.2016.1270236.

PMID:
28010175
27.

The effect of extremity strength training on fibromyalgia symptoms and disease impact in an existing multidisciplinary treatment program.

Kas T, Colby M, Case M, Vaughn D.

J Bodyw Mov Ther. 2016 Oct;20(4):774-783. doi: 10.1016/j.jbmt.2016.01.005. Epub 2016 Jan 29.

PMID:
27814858
28.

Flood-induced transport of PAHs from streambed coal tar deposits.

Vulava VM, Vaughn DS, McKay LD, Driese SG, Cooper LW, Menn FM, Levine NS, Sayler GS.

Sci Total Environ. 2017 Jan 1;575:247-257. doi: 10.1016/j.scitotenv.2016.09.222. Epub 2016 Oct 12.

PMID:
27744153
29.

Pullout strength of monocortical and bicortical screws in metaphyseal and diaphyseal regions of the canine humerus.

Vaughn DP, Syrcle JA, Ball JE, Elder SH, Gambino JM, Griffin RL, McLaughlin RM.

Vet Comp Orthop Traumatol. 2016 Nov 23;29(6):466-474. Epub 2016 Oct 6.

PMID:
27709222
30.

Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample.

Taylor S, Lopez P, Weckx L, Borja-Tabora C, Ulloa-Gutierrez R, Lazcano-Ponce E, Kerdpanich A, Angel Rodriguez Weber M, Mascareñas de Los Santos A, Tinoco JC, Safadi MA, Lim FS, Hernandez-de Mezerville M, Faingezicht I, Cruz-Valdez A, Feng Y, Li P, Durviaux S, Haars G, Roy-Ghanta S, Vaughn DW, Nolan T.

J Infect. 2017 Jan;74(1):29-41. doi: 10.1016/j.jinf.2016.09.003. Epub 2016 Sep 22.

PMID:
27667752
31.

Efficacy of the nanoparticle-drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I-IIa clinical trial.

Keefe SM, Hoffman-Censits J, Cohen RB, Mamtani R, Heitjan D, Eliasof S, Nixon A, Turnbull B, Garmey EG, Gunnarsson O, Waliki M, Ciconte J, Jayaraman L, Senderowicz A, Tellez AB, Hennessy M, Piscitelli A, Vaughn D, Smith A, Haas NB.

Ann Oncol. 2016 Aug;27(8):1579-85. doi: 10.1093/annonc/mdw188. Epub 2016 Jun 8.

32.

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.

Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, Monahan PO, Feldman DR, Hamilton R, Vaughn DJ, Beard CJ, Budnick A, Johnson EM, Ardeshir-Rouhani-Fard S, Einhorn LH, Lipshultz SE, Dolan ME, Travis LB.

J Clin Oncol. 2016 Aug 10;34(23):2712-20. doi: 10.1200/JCO.2016.66.8822. Epub 2016 Jun 27.

33.

Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors.

Narayan V, Gunnarsson O, Hwang WT, Squillante CM, Nathanson KL, Stadtmauer EA, Vaughn DJ.

Clin Genitourin Cancer. 2016 Dec;14(6):524-529. doi: 10.1016/j.clgc.2016.03.015. Epub 2016 Mar 24.

PMID:
27083130
34.

Cyclin-Dependent Kinase 4/6 Inhibition for the Treatment of Unresectable Mature Teratoma: Long-Term Follow-Up of a Phase II Study.

Narayan V, Hwang WT, Lal P, Rosen MA, Gallagher M, O'Dwyer PJ, Vaughn DJ.

Clin Genitourin Cancer. 2016 Dec;14(6):504-510. doi: 10.1016/j.clgc.2016.03.010. Epub 2016 Mar 12.

PMID:
27055371
35.

"Let's not forget our Raison d'etre".

Vaughn D.

J Man Manip Ther. 2015 Dec;23(5):237-8. doi: 10.1080/10669817.2015.1130485. No abstract available.

36.

Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection.

Clapham HE, Rodriguez-Barraquer I, Azman AS, Althouse BM, Salje H, Gibbons RV, Rothman AL, Jarman RG, Nisalak A, Thaisomboonsuk B, Kalayanarooj S, Nimmannitya S, Vaughn DW, Green S, Yoon IK, Cummings DA.

J Infect Dis. 2016 May 1;213(9):1428-35. doi: 10.1093/infdis/jiv759. Epub 2015 Dec 23.

37.

Insufficient Clarity of Statement 6 in the Consensus Opinions to Prevent Neurologic Complications after Epidural Steroid Injections.

Vaughn DR.

Anesthesiology. 2016 Jan;124(1):241-3. doi: 10.1097/ALN.0000000000000928. No abstract available.

PMID:
26669992
38.

Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer.

Narayan V, Mamtani R, Keefe S, Guzzo T, Malkowicz SB, Vaughn DJ.

Cancer Res Treat. 2016 Jul;48(3):1084-91. doi: 10.4143/crt.2015.405. Epub 2015 Dec 2.

39.

Palbociclib (PD0332991)-a Selective and Potent Cyclin-Dependent Kinase Inhibitor: A Review of Pharmacodynamics and Clinical Development.

Clark AS, Karasic TB, DeMichele A, Vaughn DJ, O'Hara M, Perini R, Zhang P, Lal P, Feldman M, Gallagher M, O'Dwyer PJ.

JAMA Oncol. 2016 Feb;2(2):253-60. doi: 10.1001/jamaoncol.2015.4701. Review.

PMID:
26633733
40.

Assessment of Prime-boost Vaccination Using an AS03B-adjuvanted Influenza A (H5N1) Vaccine: A Randomized Trial in Children of Three to Less Than Eighteen Years of Age.

Izurieta P, Uy-Aragon MJ, Dramé M, Vaughn DW.

Pediatr Infect Dis J. 2016 Feb;35(2):e35-47. doi: 10.1097/INF.0000000000000968.

PMID:
26551446
41.

The best is yet to come: 2015 and beyond.

Vaughn D.

J Man Manip Ther. 2015 Feb;23(1):1. doi: 10.1179/1066981714Z.000000000122. No abstract available.

42.

Psychological Predictors of Outcomes with Lumbar Spinal Fusion: A Systematic Literature Review.

Wilhelm M, Reiman M, Goode A, Richardson W, Brown C, Vaughn D, Cook C.

Physiother Res Int. 2017 Apr;22(2). doi: 10.1002/pri.1648. Epub 2015 Aug 13. Review.

PMID:
26270324
43.

Association Among Hypoxemia, Patent Foramen Ovale, and Mediastinal Germ Cell Tumor: A Case Report.

Offin MD, Menachem J, Squillante C, Ky B, Vaughn D, Carver J.

Ann Intern Med. 2015 Aug 4;163(3):243-4. doi: 10.7326/L15-5120. No abstract available.

PMID:
26237762
44.

Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes.

Lewis JD, Habel LA, Quesenberry CP, Strom BL, Peng T, Hedderson MM, Ehrlich SF, Mamtani R, Bilker W, Vaughn DJ, Nessel L, Van Den Eeden SK, Ferrara A.

JAMA. 2015 Jul 21;314(3):265-77. doi: 10.1001/jama.2015.7996.

PMID:
26197187
45.

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials.

Vesikari T, Richardus JH, Berglund J, Korhonen T, Flodmark CE, Lindstrand A, Silfverdal SA, Bambure V, Caplanusi A, Dieussaert I, Roy-Ghanta S, Vaughn DW.

Pediatr Infect Dis J. 2015 Jul;34(7):774-82. doi: 10.1097/INF.0000000000000709.

PMID:
26069949
46.

Reply to J. Beyer, T. Tandstad et al, S. Gillessen et al, J. Oldenburg et al, and L.C. Pagliaro et al.

Vaughn DJ.

J Clin Oncol. 2015 Jul 10;33(20):2324-5. doi: 10.1200/JCO.2015.61.4834. Epub 2015 Jun 1. No abstract available.

PMID:
26033814
47.

Immunogenicity and safety of an AS03-adjuvanted H5N1 pandemic influenza vaccine in Korean adults: a phase IV, randomized, open-label, controlled study.

Izurieta P, Kim WJ, Wie SH, Lee J, Lee JS, Dramé M, Vaughn DW, Schuind A.

Vaccine. 2015 Jun 4;33(24):2800-7. doi: 10.1016/j.vaccine.2015.04.027. Epub 2015 Apr 21.

48.

The caregiver's perspective.

Urbanski B, Vaughn DC.

Health Prog. 2014 Nov-Dec;95(6):48-50. No abstract available.

PMID:
25682673
49.

Prevalence and Incidence of Respiratory Syncytial Virus and Other Respiratory Viral Infections in Children Aged 6 Months to 10 Years With Influenza-like Illness Enrolled in a Randomized Trial.

Nolan T, Borja-Tabora C, Lopez P, Weckx L, Ulloa-Gutierrez R, Lazcano-Ponce E, Kerdpanich A, Weber MA, Mascareñas de Los Santos A, Tinoco JC, Safadi MA, Seng LF, Hernandez-de Mezerville M, Faingezicht I, Cruz-Valdez A, Feng Y, Li P, Durviaux S, Haars G, Roy-Ghanta S, Vaughn DW, Taylor S.

Clin Infect Dis. 2015 Jun 1;60(11):e80-9. doi: 10.1093/cid/civ065. Epub 2015 Feb 11.

50.

Pharmacokinetic and toxicity considerations in the use of neoadjuvant chemotherapy for bladder cancer.

Narayan V, Vaughn D.

Expert Opin Drug Metab Toxicol. 2015 May;11(5):731-42. doi: 10.1517/17425255.2015.1005600. Epub 2015 Jan 21. Review.

PMID:
25604887

Supplemental Content

Loading ...
Support Center